Fifth Third Bancorp Sarepta Therapeutics, Inc. Transaction History
Fifth Third Bancorp
- $27.1 Billion
- Q4 2024
A detailed history of Fifth Third Bancorp transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 1,832 shares of SRPT stock, worth $212,676. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,832
Previous 573
219.72%
Holding current value
$212,676
Previous $71,000
212.68%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding SRPT
# of Institutions
528Shares Held
83.9MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.2 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.04 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$727 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$506 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$496 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.2B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...